S. KILIÇKAP Et Al. , "CRIZOTINIB EFFICACY IN ALK-POSITIVE ADVANCEDSTAGE NON-SMALL CELL LUNG CANCER PATIENTS: A REAL-WORLD EXPERIENCE FROM TURKEY," IASLC 2018 , 2018
KILIÇKAP, S. Et Al. 2018. CRIZOTINIB EFFICACY IN ALK-POSITIVE ADVANCEDSTAGE NON-SMALL CELL LUNG CANCER PATIENTS: A REAL-WORLD EXPERIENCE FROM TURKEY. IASLC 2018 .
KILIÇKAP, S., ÖZTÜRK, a., KARADURMUŞ, N., KORKMAZ, T., YUMUK, P. F., ÇİÇİN, İ., ... PAYDAŞ, S.(2018). CRIZOTINIB EFFICACY IN ALK-POSITIVE ADVANCEDSTAGE NON-SMALL CELL LUNG CANCER PATIENTS: A REAL-WORLD EXPERIENCE FROM TURKEY . IASLC 2018
KILIÇKAP, SAADETTİN Et Al. "CRIZOTINIB EFFICACY IN ALK-POSITIVE ADVANCEDSTAGE NON-SMALL CELL LUNG CANCER PATIENTS: A REAL-WORLD EXPERIENCE FROM TURKEY," IASLC 2018, 2018
KILIÇKAP, SAADETTİN Et Al. "CRIZOTINIB EFFICACY IN ALK-POSITIVE ADVANCEDSTAGE NON-SMALL CELL LUNG CANCER PATIENTS: A REAL-WORLD EXPERIENCE FROM TURKEY." IASLC 2018 , 2018
KILIÇKAP, S. Et Al. (2018) . "CRIZOTINIB EFFICACY IN ALK-POSITIVE ADVANCEDSTAGE NON-SMALL CELL LUNG CANCER PATIENTS: A REAL-WORLD EXPERIENCE FROM TURKEY." IASLC 2018 .
@conferencepaper{conferencepaper, author={SAADETTİN KILIÇKAP Et Al. }, title={CRIZOTINIB EFFICACY IN ALK-POSITIVE ADVANCEDSTAGE NON-SMALL CELL LUNG CANCER PATIENTS: A REAL-WORLD EXPERIENCE FROM TURKEY}, congress name={IASLC 2018}, city={}, country={}, year={2018}}